Immunovant, Inc. IMVT Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s common stock shares outstanding?
- Immunovant, Inc. (IMVT) reported common stock shares outstanding of $117.2M in Q4 2025.
- How has Immunovant, Inc.'s common stock shares outstanding changed year-over-year?
- Immunovant, Inc.'s common stock shares outstanding decreased by 34.5% year-over-year, from $178.9M to $117.2M.
- What is the long-term trend for Immunovant, Inc.'s common stock shares outstanding?
- Over 4 years (2021 to 2025), Immunovant, Inc.'s common stock shares outstanding has grown at a 36.1% compound annual growth rate (CAGR), from $25.96M to $88.96M.
- What does common stock shares outstanding mean?
- This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.